286 related articles for article (PubMed ID: 10502325)
21. Mapping of chromosome 3p deletions in human epithelial ovarian tumors.
Lounis H; Mes-Masson AM; Dion F; Bradley WE; Seymour RJ; Provencher D; Tonin PN
Oncogene; 1998 Nov; 17(18):2359-65. PubMed ID: 9811467
[TBL] [Abstract][Full Text] [Related]
22. 11q13 allelic loss in pituitary tumors in patients with multiple endocrine neoplasia syndrome type 1.
Weil RJ; Vortmeyer AO; Huang S; Boni R; Lubensky IA; Pack S; Marx SJ; Zhuang Z; Oldfield EH
Clin Cancer Res; 1998 Jul; 4(7):1673-8. PubMed ID: 9676841
[TBL] [Abstract][Full Text] [Related]
23. Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas.
Välimäki S; Forsberg L; Farnebo LO; Larsson C
Int J Oncol; 2002 Oct; 21(4):727-35. PubMed ID: 12239610
[TBL] [Abstract][Full Text] [Related]
24. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
[TBL] [Abstract][Full Text] [Related]
25. Frequent loss of heterozygosity at chromosome 3p14.2-3p21 in human pancreatic islet cell tumours.
Nikiforova MN; Nikiforov YE; Biddinger P; Gnepp DR; Grosembacher LA; Wajchenberg BL; Fagin JA; Cohen RM
Clin Endocrinol (Oxf); 1999 Jul; 51(1):27-33. PubMed ID: 10468962
[TBL] [Abstract][Full Text] [Related]
26. Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.
Khosla S; Patel VM; Hay ID; Schaid DJ; Grant CS; van Heerden JA; Thibodeau SN
J Clin Invest; 1991 May; 87(5):1691-9. PubMed ID: 2022740
[TBL] [Abstract][Full Text] [Related]
27. Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma.
Yatsuoka T; Sunamura M; Furukawa T; Fukushige S; Yokoyama T; Inoue H; Shibuya K; Takeda K; Matsuno S; Horii A
Am J Gastroenterol; 2000 Aug; 95(8):2080-5. PubMed ID: 10950061
[TBL] [Abstract][Full Text] [Related]
28. Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome.
Anlauf M; Schlenger R; Perren A; Bauersfeld J; Koch CA; Dralle H; Raffel A; Knoefel WT; Weihe E; Ruszniewski P; Couvelard A; Komminoth P; Heitz PU; Klöppel G
Am J Surg Pathol; 2006 May; 30(5):560-74. PubMed ID: 16699310
[TBL] [Abstract][Full Text] [Related]
29. Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract.
Pizzi S; Azzoni C; Bassi D; Bottarelli L; Milione M; Bordi C
Cancer; 2003 Sep; 98(6):1273-82. PubMed ID: 12973852
[TBL] [Abstract][Full Text] [Related]
30. Exclusion of SMAD4 mutation as an early genetic change in human pancreatic ductal tumorigenesis.
Inoue H; Furukawa T; Sunamura M; Takeda K; Matsuno S; Horii A
Genes Chromosomes Cancer; 2001 Jul; 31(3):295-9. PubMed ID: 11391801
[TBL] [Abstract][Full Text] [Related]
31. A possible tumor suppressor gene for parathyroid adenomas.
Iwasaki H
Int Surg; 1996; 81(1):71-6. PubMed ID: 8803711
[TBL] [Abstract][Full Text] [Related]
32. Allelic loss on chromosome 11 in hereditary and sporadic tumors related to familial multiple endocrine neoplasia type 1.
Bale AE; Norton JA; Wong EL; Fryburg JS; Maton PN; Oldfield EH; Streeten E; Aurbach GD; Brandi ML; Friedman E
Cancer Res; 1991 Feb; 51(4):1154-7. PubMed ID: 1671755
[TBL] [Abstract][Full Text] [Related]
33. Multiple endocrine neoplasia type 1: atypical presentation, clinical course, and genetic analysis of multiple tumors.
Vortmeyer AO; Lubensky IA; Skarulis M; Li G; Moon YW; Park WS; Weil R; Barlow C; Spiegel AM; Marx SJ; Zhuang Z
Mod Pathol; 1999 Sep; 12(9):919-24. PubMed ID: 10496602
[TBL] [Abstract][Full Text] [Related]
34. Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors.
Chung DC; Brown SB; Graeme-Cook F; Tillotson LG; Warshaw AL; Jensen RT; Arnold A
Cancer Res; 1998 Aug; 58(16):3706-11. PubMed ID: 9721882
[TBL] [Abstract][Full Text] [Related]
35. Evidence that loss of chromosome 18q is associated with tumor progression.
Frank CJ; McClatchey KD; Devaney KO; Carey TE
Cancer Res; 1997 Mar; 57(5):824-7. PubMed ID: 9041179
[TBL] [Abstract][Full Text] [Related]
36. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.
Crabtree JS; Scacheri PC; Ward JM; Garrett-Beal L; Emmert-Buck MR; Edgemon KA; Lorang D; Libutti SK; Chandrasekharappa SC; Marx SJ; Spiegel AM; Collins FS
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1118-23. PubMed ID: 11158604
[TBL] [Abstract][Full Text] [Related]
37. Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11.
Thakker RV; Bouloux P; Wooding C; Chotai K; Broad PM; Spurr NK; Besser GM; O'Riordan JL
N Engl J Med; 1989 Jul; 321(4):218-24. PubMed ID: 2568587
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability.
Scacheri PC; Kennedy AL; Chin K; Miller MT; Hodgson JG; Gray JW; Marx SJ; Spiegel AM; Collins FS
Cancer Res; 2004 Oct; 64(19):7039-44. PubMed ID: 15466197
[TBL] [Abstract][Full Text] [Related]
39. Somatic mutations of multiple endocrine neoplasia type 1 gene in the sporadic endocrine tumors.
Shan L; Nakamura Y; Nakamura M; Yokoi T; Tsujimoto M; Arima R; Kameya T; Kakudo K
Lab Invest; 1998 Apr; 78(4):471-5. PubMed ID: 9564891
[TBL] [Abstract][Full Text] [Related]
40. Clonal analysis by chromosome 11 microsatellite-PCR of microdissected parathyroid tumors from MEN 1 patients.
Morelli A; Falchetti A; Amorosi A; Tonelli F; Bearzi I; Ranaldi R; Tomassetti P; Brandi ML
Biochem Biophys Res Commun; 1996 Oct; 227(3):736-42. PubMed ID: 8886003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
